a Comparison of Lipid Profile in Ischemic Stroke Patiens with Diabetes Mellitus and Non-Diabetes Mellitus at Rumah Sakit Umum Daerah Ciamis 2020
Keywords:Ischemic stroke, diabetes mellitus, lipid profile, dyslipidemia.
Diabetes mellitus causes lipid profile abnormalities, resulting in dyslipidemia in diabetic patients leading to ischemic stroke. This research aims to contrast lipid profiles in ischemic stroke patients with type 2 diabetes mellitus (T2DM) and non-type 2 diabetes mellitus (non-T2DM) to prevent stroke recurrence, treat dyslipidemia in diabetes mellitus, and evaluate for treatment of T2DM and non-T2DM ischemic stroke patients. A cross-sectional design was conducted at RSUD Ciamis using secondary medical record data in 2020. The data was collected using a nonprobability sampling approach, with the sampling extent determined by inclusion and exclusion criteria. Univariate analysis was used to determine the quantity and calculation. Besides, an independent t-test and chi-square test was utilized to test two hypotheses in bivariate analysis. Multifaceted analysis in age, gender, hypertension, and coronary heart disease was incorporated to observe its influence on T2DM and non-T2DM ischemic stroke patients. By using four lipid profile indicators, the differences were only in the triglyceride. While the total cholesterol, low-density lipoprotein (LDL), and high-density lipoprotein (HDL) were insignificant. Meanwhile, hypertension and coronary heart disease (CHD) significantly affect the incidence of ischemic stroke.
World Health Organisation (WHO). WHO definition of palliative care. 2016; Available from: http//www.who.int/cancer/palliative/definition/en
Aman AM, Soewondo P, Soelistijo AS, Arsana MP, Wismandari, Zufry H, et al. Pedoman Pengelolaan Dislipidemia di Indonesia. 2019. 5–7 p.
Jameson JL, Fauci A, Kasper D, Hauser S, Longo D, Loscalzo J. Harrison’s Principles of Internal Medicine. 20th ed. McGraw-Hill; 2018. 2892 p.
Jameson JL. Harrison’s Endocrinology. 4th ed. McGraw-Hill; 2016. 608–609 p.
Chaudhury D, Ankita A. Diabetic dyslipidemia: Current concepts in pathophysiology and management. J Clin Diagnostic Res. 2018;12(1).
Haffner SM. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA J Am Med Assoc. 1990;263(21):2893–8.
Dean D, Durrington P. Treatment of dyslipoproteinaemia in diabetes mellitus. Diabet Med A J Br Diabet Assoc. 1996;13(4):297–312.
Verges B. Pathophysiology of diabetic dyslipidaemia: Where are we? Diabetologia. 2015;58(5):886–899.
Schofield J, Liu Y, Rao-Balakrishna P, Malik R, Soran H. Diabetes dyslipidemia. Diabetes Ther Res Treat Educ Diabetes Relat Disord. 2016;7(2):203–219.
Galicia-Garcia C, Benito-Vicente U, Jebari A, Larrea-Sebal S, Siddiqi A, Uribe H, et al. Pathophysiology of type 2 diabetes mellitus. Int J Mol Sci. 2020;21(17):6275.
Badan Penelitian dan Pengembangan Kesehatan Kementrian Kesehatan RI. Laporan Nasional Riskesdas. 2018.
Riyadina W, Ekowati R. Determinan penyakit stroke. Kesmas Natl Public Heal J. 2013;7(7):324.
Saputra M, Muhith A, Fardiansyah A. Analisis sistem informasi faktor resiko hipertensi berbasis posbindu di dinas keseharan kabupaten sidoarjo. Pros Semin Nas Seri Ke-1. 2017;7(17).
Feske S. Ischemic stroke. Am J Med. 2021;
Doucet J, Le-Floch JP, Bauduceau B, Verny C, Intergroup S. GERODIAB: Glycaemic control and 5-year morbidity/mortality of type 2 diabetic patients aged 70 years and older: 1. Description of the population at inclusion. Diabetes Metab [Internet]. 2012;38(6):523–30. Available from: https://pubmed.ncbi.nlm.nih.gov/23062595/
Lik-Hui L, Jeremy L, Karen B, Vincent T, Elif E. The prevalence of Diabetes and its effects on Stroke Outcomes; a meta-analysis and literature review. J Diabetes Investig. 2018;10(3):780–92.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Am Diabetes Assoc. 2013;36(Supplement_1):67–74.
Taskinen MR. Diabetic dyslipidaemia: From basic research to clinical practice. Diabetologia [Internet]. 2003;46:733–749. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392164/#CR6
RI BP dan PKKK. Laporan hasil riset kesehatan dasar (RISKESDAS) Provinsi Jawa Barat tahun 2007. Kementrian Kesehat. 2007;
Chen W, Pan Y, Jing J, Zhao X, Liu L, Meng X, et al. Recurrent stroke in minor ischemic stroke or transient ischemic attack with metabolic syndrome and diabetes mellitus. J Am Heart Assoc. 2017;6(6).
Seung-Hoon L. Stroke Revisited: Pathophysiology of Stroke: From Bench to Bedside. 1st ed. Springer; 2020. 288–304 p.
Corbett D, Carmichael S, Murphy T, Jones T, Schwab M, Jolkkonen J, et al. Enhancing the alignment of the preclinical and clinical stroke recovery research pipeline: Consensus-based core recommendations from the stroke recovery and rehabilitation roundtable translational working group. International J Stroke. 2017;12(5):462–71.
Jeetendrakumar J, Ashoka A, Chethan C, Shivraj S, Umesh U. A comparative study of lipid profile in ischemic stroke between diabetic and non-diabetic patients at a tertiary care center. J Evol Med Dent Sci. 2015;4(29):2278–4748.
Holanda MDA, Filizola R, Costa DCC, De Andrade R, Gonçalves DS. Plasma lipoprotein(A) levels: A comparison between diabetic and non-diabetic patients with acute ischemic stroke. Arq Neuropsiquiatr. 2004;62(2A):233–6.
Shahar E, Chambless L, Rosamond W. Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. Stroke. 2003;34(3):623–31.
Kim S, Park Y, Kim J. Plasma fasting and nonfasting triglycerides and high-density lipoprotein cholesterol in atherosclerotic stroke: Different profiles according to low-density lipoprotein cholesterol. Atherosclerosis. 2012;223(2):463–467.
Meschia J, Bushnell C, Boden-Albala B. Guidelines for the primary prevention of stroke: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(12):3754–832.
Wein T, Lindsay M, Côté R. Canadian stroke best practice recommendations: Secondary prevention of stroke, sixth edition practice guidelines, update 2017. Int J Stroke. 2018;13(4):420–43.
Iso H, Imano H, Yamagishi K. Fasting and non-fasting triglycerides and risk of ischemic cardiovascular disease in Japanese men and women: The Circulatory Risk in Communities Study (CIRCS). Atherosclerosis. 2014;237(1):361–8.
Tanne D, Koren-Morag N, Graff E. Blood lipids and first-ever ischemic stroke/transient ischemic attack in the Bezafibrate Infarction Prevention (BIP) Registry: High triglycerides constitute an independent risk factor. Circulation. 2001;104(24):2892–7.
Lindenstrom E, Boysen G, Nyboe J. Influence of total cholesterol, high-density lipoprotein cholesterol, and triglycerides on the risk of cerebrovascular disease: The Copenhagen City Heart Study. BMJ. 1994;309(6946):11–15.
Håheim L, Holme I, Hjermann I. Risk factors of stroke incidence and mortality: A 12-year follow-up of the Oslo Study. Stroke. 1993;24(10):1484–9.
Simons L, McCallum J, Friedlander Y. Risk factors for ischemic stroke: Dubbo Study of the elderly. Stroke. 1998;29(7):1341–6.
Simons L, Simons J, Friedlander Y. A comparison of risk factors for coronary heart disease and ischaemic stroke: The Dubbo study of Australian elderly. Heart Lung Circ. 2009;18(15):330–3.
Wannamethee S, Shaper A, Ebrahim S. HDL-Cholesterol, total cholesterol, and the risk of stroke in middle-aged British men. Stroke. 2000;31(8):1882–8.
Shahar E et al. Plasma lipid profile and incident ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study. 2003;34(3):623–31.
TG and HDL Working Group of the Exome Sequencing Project, National Heart, Lung, and Blood Institute, Crosby J, Peloso GM, Auer PL, Crosslin DR, Stitziel NO, Lange LA, Lu Y, Tang ZZ, Zhang H, Hindy G, Masca N, Stirrups K, Kanoni S, Do R, Jun G, Hu Y, Kang KS. Loss-of-function mutations in APOC3, triglycerides, and coronary disease. 2014;371(1):22–31.
Bowman TS. Cholesterol and the risk of ischemic stroke. 2003;34(12):2930–4.
Crosby J, Peloso G, Auer P, Crosslin D, Stitziel N, Lange L. Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N Engl J Med. 2014;371(1):22–31.
How to Cite
All articles submitted by the author and published in the Jurnal Profesi Medika : Jurnal Kedokteran dan Kesehatan, are fully copyrighted by the publication of Jurnal Profesi Medika : Jurnal Kedokteran dan Kesehatan under the Creative Commons Attribution-NonCommercial 4.0 International License by technically filling out the copyright transfer agreement and sending it to the publisher
The author can include in separate contractual arrangements for the non-exclusive distribution of rich versions of journal publications (for example: posting them to an institutional repository or publishing them in a book), with the acknowledgment of their initial publication in this journal.
Authors are permitted and encouraged to post their work online (for example: in an institutional repository or on their website) before and during the submission process because it can lead to productive exchanges, as well as earlier and more powerful citations of published works. (See Open Access Effects).